{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:37:57Z","timestamp":1778542677592,"version":"3.51.4"},"reference-count":159,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.rdc.2010.02.006","type":"journal-article","created":{"date-parts":[[2010,5,26]],"date-time":"2010-05-26T04:56:16Z","timestamp":1274849776000},"page":"345-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Targeting IL-17 and Th17 Cells in Rheumatoid Arthritis"],"prefix":"10.1016","volume":"36","author":[{"given":"Sujata","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2010.02.006_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jimmunol\/175.1.5","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986","volume":"175","author":"Mosmann","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib4","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.4049\/jimmunol.155.12.5483","article-title":"Human IL-17: a novel cytokine derived from T cells","volume":"155","author":"Yao","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/1074-7613(95)90070-5","article-title":"Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor","volume":"3","author":"Yao","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.rdc.2010.02.006_bib6","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","article-title":"T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines","volume":"183","author":"Fossiez","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib7","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/ar2838","article-title":"Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4","volume":"11","author":"Sarkar","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2010.02.006_bib8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nri954","article-title":"The lineage decisions of helper T cells","volume":"2","author":"Murphy","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib10","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2010.02.006_bib11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2010.02.006_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2010.02.006_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T\u00a0cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.rdc.2010.02.006_bib14","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20060285","article-title":"A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"Sutton","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib15","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1189\/jlb.1006610","article-title":"Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17","volume":"81","author":"Nakae","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.rdc.2010.02.006_bib16","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib18","doi-asserted-by":"crossref","first-page":"17034","DOI":"10.1073\/pnas.0708426104","article-title":"Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes","volume":"104","author":"Evans","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rdc.2010.02.006_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2010.02.006_bib20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ni.1610","article-title":"The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat","volume":"9","author":"Manel","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ni.1613","article-title":"A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses","volume":"9","author":"Volpe","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07021","article-title":"IL-21 and TGF-beta are required for differentiation of human T(H)17 cells","volume":"454","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2010.02.006_bib23","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/eji.200535239","article-title":"Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells","volume":"36","author":"Hoeve","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.rdc.2010.02.006_bib27","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ni.1663","article-title":"Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells","volume":"9","author":"Zhang","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib28","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.178.8.4901","article-title":"Stat3 and Stat4 direct development of IL-17-secreting Th cells","volume":"178","author":"Mathur","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib29","doi-asserted-by":"crossref","first-page":"34605","DOI":"10.1074\/jbc.M705100200","article-title":"IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner","volume":"282","author":"Wei","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2010.02.006_bib30","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1002\/eji.200737766","article-title":"IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells","volume":"37","author":"Fantini","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2010.02.006_bib33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature05969","article-title":"Essential autocrine regulation by IL-21 in the generation of inflammatory T cells","volume":"448","author":"Nurieva","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2010.02.006_bib34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4049\/jimmunol.178.2.732","article-title":"IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes","volume":"178","author":"Peluso","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib35","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/intimm\/dxm090","article-title":"Human CD4+ central and effector memory T\u00a0cells produce IL-21: effect on cytokine-driven proliferation of CD4+ T cell subsets","volume":"19","author":"Onoda","year":"2007","journal-title":"Int Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib36","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.4049\/jimmunol.179.8.5462","article-title":"Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F","volume":"179","author":"Kuestner","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib37","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1074\/jbc.M700499200","article-title":"Identification of an interleukin 17F\/17A heterodimer in activated human CD4+ T cells","volume":"282","author":"Wright","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rdc.2010.02.006_bib38","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.4049\/jimmunol.179.11.7791","article-title":"An IL-17F\/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment","volume":"179","author":"Liang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib39","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.22866","article-title":"Distinct regulation of interleukin-17 in human T\u00a0helper lymphocytes","volume":"56","author":"Chen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib40","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2010.02.006_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib42","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib43","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.cr.7310106","article-title":"Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes","volume":"16","author":"Chung","year":"2006","journal-title":"Cell Res"},{"key":"10.1016\/j.rdc.2010.02.006_bib44","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib45","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib46","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/j.gastro.2005.06.071","article-title":"Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts","volume":"129","author":"Andoh","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rdc.2010.02.006_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","article-title":"Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation","volume":"27","author":"Zenewicz","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.rdc.2010.02.006_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20061886","article-title":"CD4(+)CD25(\u2212)Foxp3(\u2212) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis","volume":"204","author":"Anderson","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1084\/jem.20062175","article-title":"Conventional T-bet(+)Foxp3(\u2212) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection","volume":"204","author":"Jankovic","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib50","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/ni1539","article-title":"TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology","volume":"8","author":"McGeachy","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib51","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/ni1537","article-title":"Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10","volume":"8","author":"Stumhofer","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib52","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1084\/jem.20071397","article-title":"Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model","volume":"204","author":"Hirota","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib53","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4049\/jimmunol.180.1.214","article-title":"Human T cells that are able to produce IL-17 express the chemokine receptor CCR6","volume":"180","author":"Singh","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib54","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.4049\/jimmunol.174.4.2054","article-title":"Attenuation of allergen-induced responses in CCR6\u2212\/\u2212 mice is dependent upon altered pulmonary T lymphocyte activation","volume":"174","author":"Lundy","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib55","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2230.2004.01638.x","article-title":"Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris","volume":"29","author":"Teraki","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.rdc.2010.02.006_bib56","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/eji.200324347","article-title":"CCR6 has a non-redundant role in the development of inflammatory bowel disease","volume":"33","author":"Varona","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib57","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/01.LAB.0000062854.30195.52","article-title":"Role of macrophage inflammatory protein-3alpha and its ligand CCR6 in rheumatoid arthritis","volume":"83","author":"Ruth","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.rdc.2010.02.006_bib58","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.4049\/jimmunol.175.10.6676","article-title":"Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK\/NF-kappaB-dependent signaling pathway","volume":"175","author":"Kao","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib59","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.4049\/jimmunol.167.10.6015","article-title":"Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines","volume":"167","author":"Chabaud","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib60","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.4049\/jimmunol.178.12.7525","article-title":"Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5\u2212 phenotype","volume":"178","author":"Sato","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib61","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/rheumatology\/38.3.214","article-title":"Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients","volume":"38","author":"van der Graaff","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2010.02.006_bib62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/rheumatology\/38.3.202","article-title":"Cytokine production by synovial T cells in rheumatoid arthritis","volume":"38","author":"Steiner","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2010.02.006_bib63","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2567.1999.00712.x","article-title":"Synovial fluid T cells from patients with rheumatoid arthritis are refractory to the T helper type 2 differentiation-inducing effects of interleukin-4","volume":"96","author":"Isomaki","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.rdc.2010.02.006_bib64","first-page":"1128","article-title":"Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry","volume":"27","author":"Berner","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2010.02.006_bib65","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.4049\/jimmunol.158.11.5501","article-title":"High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors","volume":"158","author":"Manoury-Schwartz","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib66","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.158.11.5507","article-title":"Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice","volume":"158","author":"Vermeire","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib67","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.62.10.983","article-title":"IFNgamma deficient C57BL\/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints","volume":"62","author":"Chu","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.02.006_bib68","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.22453","article-title":"Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17","volume":"56","author":"Chu","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib69","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E","article-title":"Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain","volume":"44","author":"Guedez","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib70","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"Murphy","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib71","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.4049\/jimmunol.179.9.6228","article-title":"Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response","volume":"179","author":"Irmler","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib72","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib73","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.20001","article-title":"Treatment with a neutralizing antimurine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion","volume":"50","author":"Lubberts","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib74","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/art.10173","article-title":"Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein","volume":"46","author":"Bush","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib75","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.21342","article-title":"Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis","volume":"52","author":"Koenders","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib76","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.175.5.3360","article-title":"Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis","volume":"175","author":"Lubberts","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib77","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/13547500802651911","article-title":"The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritis","volume":"13","author":"Stolina","year":"2008","journal-title":"Biomarkers"},{"key":"10.1016\/j.rdc.2010.02.006_bib78","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/art.23152","article-title":"T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17","volume":"58","author":"Joosten","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib79","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.1035999100","article-title":"IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist","volume":"100","author":"Nakae","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rdc.2010.02.006_bib80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20062259","article-title":"T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis","volume":"204","author":"Hirota","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib81","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/eji.1830250508","article-title":"Biphasic effect of interferon-gamma in murine collagen-induced arthritis","volume":"25","author":"Boissier","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib82","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.4049\/jimmunol.163.10.5383","article-title":"Proteoglycan (aggrecan)-induced arthritis in BALB\/c mice is a Th1-type disease regulated by Th2 cytokines","volume":"163","author":"Finnegan","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib83","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1016-8478(23)13153-0","article-title":"Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients","volume":"19","author":"Hwang","year":"2005","journal-title":"Mol Cells"},{"key":"10.1016\/j.rdc.2010.02.006_bib84","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib85","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","article-title":"High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism","volume":"164","author":"Ziolkowska","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib86","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/ar2477","article-title":"TH-17 cells in rheumatoid arthritis","volume":"10","author":"Shahrara","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2010.02.006_bib87","doi-asserted-by":"crossref","first-page":"R784","DOI":"10.1186\/ar1733","article-title":"Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin","volume":"7","author":"Raza","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2010.02.006_bib88","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1186\/ar1470","article-title":"Increased interleukin-17 production via a phosphoinositide 3-kinase\/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis","volume":"7","author":"Kim","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2010.02.006_bib89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2249.2000.01328.x","article-title":"Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls","volume":"122","author":"Lenarczyk","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/art.25064","article-title":"Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis","volume":"62","author":"von Delwig","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib91","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.21749","article-title":"Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort)","volume":"54","author":"Kirkham","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib92","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar2107","article-title":"Cells of the synovium in rheumatoid arthritis. T lymphocytes","volume":"9","author":"Lundy","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2010.02.006_bib93","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.4049\/jimmunol.0802246","article-title":"IL-17 induces monocyte migration in rheumatoid arthritis","volume":"182","author":"Shahrara","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib94","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10067-005-1081-1","article-title":"IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes","volume":"25","author":"Ryu","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2010.02.006_bib95","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.imlet.2004.01.014","article-title":"Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts","volume":"93","author":"Numasaki","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.rdc.2010.02.006_bib96","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2010.02.006_bib97","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.21731","article-title":"Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes","volume":"54","author":"Miranda-Carus","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib98","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib99","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/art.22439","article-title":"Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction","volume":"56","author":"Kim","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib100","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.4049\/jimmunol.176.9.5652","article-title":"STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice","volume":"176","author":"Cho","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib101","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10875-008-9233-0","article-title":"Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial","volume":"29","author":"Caproni","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib102","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/ar1478","article-title":"The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models","volume":"7","author":"Lubberts","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2010.02.006_bib103","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.4049\/jimmunol.176.10.6262","article-title":"Interleukin-17 acts independently of TNF-alpha under arthritic conditions","volume":"176","author":"Koenders","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib104","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T","article-title":"The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model","volume":"44","author":"Chabaud","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib105","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/art.20218","article-title":"Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis","volume":"50","author":"Jungel","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib106","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-3083.2006.01795.x","article-title":"Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis","volume":"64","author":"Li","year":"2006","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib107","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/art.22452","article-title":"Blockade of the interleukin-21\/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis","volume":"56","author":"Young","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib108","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/03009740701286813","article-title":"The clinical role of IL-23p19 in patients with rheumatoid arthritis","volume":"36","author":"Kim","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rdc.2010.02.006_bib109","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/rheumatology\/kel159","article-title":"Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways","volume":"46","author":"Kim","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2010.02.006_bib110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2119\/2007-00072.Lee","article-title":"Association of STAT4 with rheumatoid arthritis in the Korean population","volume":"13","author":"Lee","year":"2007","journal-title":"Mol Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib111","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib112","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.4049\/jimmunol.178.6.3427","article-title":"Targeting of the transcription factor STAT4 by antisense phosphorothioate oligonucleotides suppresses collagen-induced arthritis","volume":"178","author":"Hildner","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib113","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/art.20965","article-title":"Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine","volume":"52","author":"Ikeuchi","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib114","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4049\/jimmunol.173.2.1463","article-title":"IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate","volume":"173","author":"Miranda-Carus","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib115","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/eji.200737229","article-title":"IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17","volume":"37","author":"Yoshihara","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib116","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.4049\/jimmunol.173.9.5818","article-title":"Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15\/Fc protein prevents disease development and progression in murine collagen-induced arthritis","volume":"173","author":"Ferrari-Lacraz","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib117","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.4049\/jimmunol.166.4.2270","article-title":"Effector function of resting T cells: activation of synovial fibroblasts","volume":"166","author":"Yamamura","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib118","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2353\/ajpath.2007.070004","article-title":"Molecular interactions between T cells and fibroblast-like synoviocytes: role of membrane tumor necrosis factor-alpha on cytokine-activated T cells","volume":"171","author":"Tran","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2010.02.006_bib119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1359\/JBMR.051004","article-title":"Immunocompetent properties of human osteoblasts: interactions with T lymphocytes","volume":"21","author":"Stanley","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.rdc.2010.02.006_bib120","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1172\/JCI11490","article-title":"Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis","volume":"107","author":"Morita","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2010.02.006_bib121","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/art.22311","article-title":"Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4","volume":"56","author":"Sarkar","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib122","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1172\/JCI7739","article-title":"IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion","volume":"105","author":"Lubberts","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2010.02.006_bib123","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.0022-202X.2004.23448.x","article-title":"A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis","volume":"123","author":"Kauffman","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.rdc.2010.02.006_bib124","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1185\/030079907X182112","article-title":"A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12\/23 monoclonal antibody in subjects with plaque psoriasis","volume":"23","author":"Gottlieb","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rdc.2010.02.006_bib125","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa062382","article-title":"A human interleukin-12\/23 monoclonal antibody for the treatment of psoriasis","volume":"356","author":"Krueger","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib126","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2010.02.006_bib127","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2010.02.006_bib128","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1056\/NEJMoa0810652","article-title":"Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis","volume":"362","author":"Griffiths","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib129","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","article-title":"Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial","volume":"373","author":"Gottlieb","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2010.02.006_bib130","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1053\/j.gastro.2008.07.014","article-title":"A randomized trial of Ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease","volume":"135","author":"Sandborn","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rdc.2010.02.006_bib131","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1474-4422(08)70173-X","article-title":"Repeated subcutaneous injections of IL12\/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study","volume":"7","author":"Segal","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rdc.2010.02.006_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2007.06.006","article-title":"Modulation of CLA, IL-12R, CD40L, and IL-2Ralpha expression and inhibition of IL-12- and IL-23-induced cytokine secretion by CNTO 1275","volume":"247","author":"Reddy","year":"2007","journal-title":"Cell Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib133","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.4049\/jimmunol.177.7.4917","article-title":"An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12\/IL-23 in psoriasis","volume":"177","author":"Toichi","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib134","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/1529-0131(199812)41:12<2117::AID-ART6>3.0.CO;2-P","article-title":"Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis","volume":"41","author":"Takagi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib135","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1084\/jem.20020619","article-title":"A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis","volume":"196","author":"Atsumi","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.rdc.2010.02.006_bib136","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1172\/JCI113921","article-title":"Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis","volume":"83","author":"Guerne","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2010.02.006_bib137","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/art.1780310614","article-title":"Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides","volume":"31","author":"Houssiau","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib138","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/ard.52.3.232","article-title":"Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity","volume":"52","author":"Madhok","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.02.006_bib139","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.4049\/jimmunol.144.9.3347","article-title":"Quantitative analysis of cytokine gene expression in rheumatoid arthritis","volume":"144","author":"Firestein","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/ar400","article-title":"Joint disease caused by defective gp130-mediated STAT signaling","volume":"4","author":"Naka","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.rdc.2010.02.006_bib141","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1002\/art.10623","article-title":"Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial","volume":"46","author":"Choy","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib142","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/art.20303","article-title":"Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial","volume":"50","author":"Nishimoto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib143","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2008.092866","article-title":"Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study","volume":"68","author":"Nishimoto","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.02.006_bib144","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","article-title":"Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate","volume":"54","author":"Maini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib145","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2010.02.006_bib146","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.23940","volume":"58","author":"Genovese","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib147","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/ard.2008.092932","article-title":"IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial","volume":"67","author":"Emery","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.02.006_bib148","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.2008.105197","article-title":"Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study","volume":"69","author":"Jones","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.02.006_bib149","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/ard.2006.068064","article-title":"Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab","volume":"66","author":"Nishimoto","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.02.006_bib150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/s10165-008-0125-1","volume":"19","author":"Nishimoto","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.rdc.2010.02.006_bib151","first-page":"1624","article-title":"Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis","volume":"22","author":"Nagashima","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2010.02.006_bib152","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2249.2000.01272.x","article-title":"Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA)","volume":"121","author":"Kasama","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib153","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.4049\/jimmunol.152.8.4149","article-title":"Vascular endothelial growth factor. A\u00a0cytokine modulating endothelial function in rheumatoid arthritis","volume":"152","author":"Koch","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.rdc.2010.02.006_bib154","first-page":"122","article-title":"Tocilizumab inhibits structural joint damage, improves physical function, and increases DAS28 remission rates in RA patients who respond inadequately to methotrexate: the Lithe Study","volume":"68","author":"Kremer","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.02.006_bib155","first-page":"582","article-title":"Neutropenia induced by anti-interleukin-6 receptor antibody, tocilizumab","volume":"68","author":"Omata","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.02.006_bib156","doi-asserted-by":"crossref","DOI":"10.1002\/art.27334","article-title":"LY2439821, a Humanized anti-IL-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis","author":"Genovese","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib157","first-page":"125","article-title":"AIN457, an anti-IL17 antibody, shows good safety and induces clinical responses in patients with active rheumatoid arthritis (RA) despite methotrexate therapy in a randomized, double-blind proof-of-concept trial","volume":"68","author":"Durez","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.02.006_bib158","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/art.25043","article-title":"1,25-dihydroxyvitamin D(3) modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis","volume":"62","author":"Colin","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2010.02.006_bib159","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/art.25017","article-title":"Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring isothiocyanate","volume":"62","author":"Kong","year":"2010","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X10000189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X10000189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:10:11Z","timestamp":1760181011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X10000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":159,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0889857X10000189"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2010.02.006","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting IL-17 and Th17 Cells in Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2010.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}